Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria
September 2017 Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture…
Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics
We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…
Ask Industry Anything (Again) – Tuesday 28th November 2017
BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…
BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017
With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…
Joint Statement on Skilled Migration Visa Changes
July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…
BioMelbourne Network Welcomes Revisions to Skilled Migration Visas
July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…
Department of Immigration Roundtable Discussion (May 2017)
BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…
2017 Connecting Women – Charity Announced!
The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…
Joint statement on the Research & Development Tax Incentive (April 2017)
18 April 2017 Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research &…
Changes to the R&D Tax Incentive: Putting a handbrake on innovation (September 2016)
September 2016 The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive.…
Tribute to Athina Tsagarakis
The BioMelbourne Network team were saddened to hear of the passing of past staff member, Athina Tsagarakis, last week at the age of 49 years. Our condolences to Athina’s family and friends during this difficult time. Members of…
BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee
September 2015 The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for…
